Fresenius Medical Care Launches TherapyWise™ Analytics to Advance Kidney Replacement Therapy Oversight
Fresenius Medical Care has announced the introduction of TherapyWise™, a new cloud-based analytics capability designed to provide healthcare organizations with retrospective, program-level insights into kidney replacement therapy (KRT) delivered in acute care and hospital critical care environments.
TherapyWise is available within NxView™ 4.0, Fresenius Medical Care’s FDA 510(k)-cleared software platform designed for use with the NxStage® System One™ in the United States.
The new analytics capability is intended to help hospital and clinical leaders better understand how kidney replacement therapy is delivered across intensive care units and other critical care settings. By consolidating data generated during therapy delivery and presenting it through aggregated performance indicators, TherapyWise is designed to support program oversight, workflow evaluation, and quality improvement discussions.
The launch comes as hospitals increasingly seek new ways to use healthcare data to improve visibility into complex clinical services. Kidney replacement therapy in the intensive care unit can generate significant amounts of clinical and operational information. However, without standardized metrics and aggregated views, it can be difficult for healthcare leaders to identify trends across multiple patients, treatment sessions, units, and time periods.
TherapyWise is designed to address this challenge by transforming existing therapy data into longitudinal summaries and program-level analytics.
Addressing the Complexity of Critical Care Kidney Replacement Therapy
Kidney replacement therapy is an important treatment for critically ill patients experiencing acute kidney injury or other forms of severe renal dysfunction.
In intensive care settings, treatment can be complex. Patients may require therapy over extended periods, while clinical teams must manage treatment parameters, workflow requirements, equipment performance, and interruptions.
The delivery of therapy can generate information related to treatment duration, prescribed and delivered therapy, cartridge utilization, alarms, and other operational factors.
At the individual patient level, clinicians use their expertise to make treatment decisions. However, at the program level, healthcare leaders may need a broader view of how therapy is being delivered across an entire hospital or group of intensive care units.
Questions may include whether delivered treatment generally aligns with prescribed therapy, how long treatment sessions typically last, whether interruptions are occurring frequently, and whether alarm trends have changed over time.
TherapyWise is designed to provide a structured way to review this type of information.
By aggregating data across therapy sessions, the platform can help leaders identify patterns that may not be readily visible when reviewing individual patient records or isolated treatment events.
Converting Existing Data Into Program-Level Insights
TherapyWise works by securely transmitting data from the NxStage System One with NxView to a cloud-based platform.
The information is then aggregated and displayed through predefined performance indicators.
The goal is to provide hospital leaders and clinical teams with a consolidated view of kidney replacement therapy activity.
Rather than requiring teams to manually gather information from multiple sources, the platform is designed to present relevant data in a format that can support retrospective analysis.
The analytics may help healthcare organizations review trends over time and compare performance across different periods or units.
This type of information can support conversations about workflow consistency, therapy delivery, operational challenges, and potential areas for improvement.
The platform includes metrics such as average delivered dose compared with the set dose, average treatment time per cartridge, and trends in alarm frequency.
These indicators can provide insight into how therapy is being delivered at the program level.
For example, differences between prescribed and delivered dose may prompt healthcare teams to examine workflow factors or treatment conditions. Similarly, changes in average treatment duration or alarm frequency may help identify trends that warrant further evaluation.
The purpose of these analytics is to support oversight and quality improvement rather than replace clinical judgment.
Supporting Hospital and Clinical Leaders
The introduction of TherapyWise reflects the growing role of data analytics in hospital operations and clinical program management.
Healthcare organizations are increasingly seeking ways to move beyond individual data points and develop a broader understanding of how services are delivered across their institutions.
In critical care, this can be particularly important because treatment processes may involve multiple clinicians, departments, and workflows.
Program-level analytics can help leaders evaluate performance over time and support discussions between clinical and operational teams.
Joe Turk, Chief Executive Officer of Care Enablement at Fresenius Medical Care, said the company is continuing to focus on digital solutions that help critical care teams better understand complex therapies.
“Digital solutions play an increasingly important role in how critical care teams understand and manage complex therapies,” Turk said.
“TherapyWise reflects our continued focus on innovation in critical care by applying data analytics. This helps hospital and clinical leaders gain visibility into how kidney replacement therapy is delivered across their organizations, supporting informed discussions around workflow, consistency, and quality improvement,” he added.
The platform is designed to support these discussions by providing consistent metrics that can be reviewed across different time periods and program settings.
Retrospective Analysis for Quality Improvement
A key feature of TherapyWise is its focus on retrospective analysis.
The platform is intended to help healthcare teams examine historical treatment data and identify trends.
This approach can support quality improvement initiatives by allowing organizations to review what has occurred and determine whether changes in practice or workflow may be beneficial.
For example, a hospital may review alarm frequency over time to determine whether patterns have changed. A program may also examine average delivered dose compared with the prescribed dose or evaluate treatment duration trends.
These analyses can provide a foundation for further investigation.
If a trend is identified, clinical and operational leaders can determine whether additional review is necessary.
The data may also support discussions about training, workflow processes, equipment use, and program consistency.
Importantly, TherapyWise is not designed to provide real-time, patient-specific clinical decision-making.
Treatment decisions remain the responsibility of attending clinicians and other qualified healthcare professionals.
This distinction is important in critical care environments, where patient conditions can change rapidly and treatment decisions must be based on the individual clinical circumstances of each patient.
TherapyWise is instead intended to provide a broader, retrospective view of program performance.
Supporting Consistency Across KRT Programs
Hospitals may have multiple intensive care units and teams involved in the delivery of kidney replacement therapy.
Ensuring consistency across these settings can be challenging.
Different units may have different workflows, staffing models, and patient populations. Without standardized data, it can be difficult to compare trends or determine whether differences reflect patient complexity, operational practices, or other factors.
TherapyWise provides predefined performance indicators that are designed to support more consistent review.
By consolidating information across therapy sessions and time periods, the platform may help healthcare leaders develop a clearer understanding of program performance.
This can support efforts to identify variation and determine whether additional standardization may be appropriate.
Program leaders may also use the information to support internal quality improvement initiatives.
The ability to track trends over time may help organizations evaluate whether changes in workflow or practice are associated with changes in performance indicators.
The Role of Cloud-Based Analytics in Critical Care
The cloud-based design of TherapyWise reflects a broader shift toward secure digital infrastructure in healthcare.
Cloud technologies can provide a way to aggregate and analyze data generated across multiple devices and locations.
For healthcare organizations, this can support the development of centralized views of clinical and operational performance.
In the case of kidney replacement therapy, information generated at the point of care can be securely transmitted to a cloud-based platform for aggregation and analysis.
This allows program-level data to be viewed across predefined indicators.
The approach can help reduce reliance on manual data collection and analysis.
It also provides a foundation for longitudinal review, allowing healthcare teams to examine trends over time rather than focusing only on individual treatment sessions.
As hospitals continue to generate increasing volumes of clinical data, digital tools that can organize and interpret this information may become increasingly important.
Part of the NxView 4.0 Platform
TherapyWise is part of NxView 4.0, Fresenius Medical Care’s software platform used with the NxStage System One in the United States.
The platform is part of the company’s broader critical care portfolio, which combines digital infrastructure, clinical expertise, and secure data management.
The integration of TherapyWise into NxView is intended to connect therapy delivery data with analytics capabilities.
This can provide healthcare organizations with a more comprehensive approach to managing kidney replacement therapy programs.
The company’s broader strategy reflects the increasing integration of medical devices and software.
As connected medical technologies generate more data, manufacturers are developing digital tools that can help healthcare professionals use that information for oversight and improvement.
The result is an evolving healthcare environment in which medical devices are increasingly connected to analytics platforms and digital workflows.
Supporting Data-Driven Program Management
Kidney replacement therapy programs can involve significant clinical and operational complexity.
Healthcare leaders must consider patient needs, clinical outcomes, treatment delivery, staffing, workflow, equipment, and resource utilization.
Program-level analytics can help provide additional visibility into how these factors relate to therapy delivery.
TherapyWise is designed to support informed discussions rather than provide automated clinical decisions.
The data can help leaders identify areas for further examination and support conversations among nephrology, critical care, nursing, biomedical engineering, and hospital administration teams.
This type of multidisciplinary approach may be important for improving the consistency and efficiency of complex therapies.
By providing a common set of performance indicators, analytics tools can help different stakeholders review the same information and discuss potential opportunities for improvement.
The Future of Digital Kidney Care
The launch of TherapyWise reflects a broader trend toward the use of digital technologies in kidney care.
Historically, many healthcare decisions relied on individual patient records and manual reporting.
Today, healthcare organizations increasingly have access to large volumes of data generated by connected medical devices and digital systems.
The challenge is to convert that information into useful insights.
Cloud-based analytics platforms may help hospitals move toward more data-driven program management.
For kidney replacement therapy, this can include reviewing therapy delivery, treatment duration, dose, alarms, and other indicators.
As technologies continue to develop, future analytics platforms may provide even greater insight into clinical workflows and program performance.
However, the appropriate use of analytics will continue to require careful consideration of clinical context and professional judgment.
Data can identify patterns, but clinicians and healthcare leaders must interpret those patterns within the context of individual patients and specific hospital environments.
Advancing Visibility Into Critical Care Therapy
With the introduction of TherapyWise, Fresenius Medical Care is expanding the digital capabilities associated with its kidney replacement therapy portfolio.
The platform is designed to help healthcare organizations gain greater visibility into how therapy is delivered across acute and critical care settings.
By securely aggregating data from the NxStage System One with NxView, TherapyWise provides retrospective summaries based on predefined performance indicators.
These insights can help healthcare leaders evaluate trends, identify areas for discussion, and support quality improvement initiatives.
The platform is not intended to replace clinicians or make real-time patient-specific treatment decisions. Instead, it provides a program-level view that can support oversight and analysis.
As hospitals continue to manage complex patient populations and increasingly data-intensive clinical environments, tools that help organize and interpret information may become increasingly valuable.
TherapyWise represents Fresenius Medical Care’s continued investment in digital healthcare solutions designed to support critical care teams.
By combining connected medical devices, secure cloud infrastructure, clinical expertise, and analytics, the company aims to help healthcare organizations better understand kidney replacement therapy delivery.
The introduction of TherapyWise marks another step in the evolution of data-enabled critical care. As hospitals seek to improve consistency, identify opportunities for quality improvement, and strengthen program oversight, analytics capabilities may play an increasingly important role.
Through its integration into NxView 4.0, TherapyWise is designed to give hospital and clinical leaders a clearer view of kidney replacement therapy trends across their programs, helping support informed discussions about workflow, performance, and continuous improvement.
Source link: https://freseniusmedicalcare.com/
